Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
Xiaoying Hou, Pei Zhang, Hongzhi Du, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Live Biotherapeutic Lactococcus lactis GEN3013 Enhances Antitumor Efficacy of Cancer Treatment via Modulation of Cancer Progression and Immune System
Sujeong Kim, Yun-Jae Kim, Suro Lee, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4083-4083
Open Access | Times Cited: 15
Beta-Glucan from S. cerevisiae Protected AOM-Induced Colon Cancer in cGAS-Deficient Mice Partly through Dectin-1-Manipulated Macrophage Cell Energy
Sulaiman Binmama, Cong Phi Dang, Peerapat Visitchanakun, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10951-10951
Open Access | Times Cited: 15
A chemical derivatization-based pseudotargeted LC-MS/MS method for high coverage determination of dipeptides
Shaoran Tang, Pei Zhang, Meiyu Gao, et al.
Analytica Chimica Acta (2023) Vol. 1274, pp. 341570-341570
Closed Access | Times Cited: 8
Intermittent Fasting against Cancer Development and Progression: Highlighting Potential Anticancer Molecular Mechanisms
Evmorfia Psara, Efthymios Poulios, Sousana Κ. Papadopoulou, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1889-1909
Closed Access | Times Cited: 7
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
Xing He, Huanrong Lan, Ketao Jin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Akkermansia muciniphila: The state of the art, 18 years after its first discovery
Rim Iwaza, Reham Magdy Wasfy, G Dubourg, et al.
Frontiers in Gastroenterology (2022) Vol. 1
Open Access | Times Cited: 12
Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study
Rana H. Abo-Hammam, Mohammed Salah, Sarah Shabayek, et al.
AIMS Microbiology (2024) Vol. 10, Iss. 1, pp. 148-160
Open Access | Times Cited: 2
Berberine attenuates 5-fluorouracil-induced intestinal mucosal injury by modulating the gut microbiota without compromising its anti-tumor efficacy
Changhong Wu, Jie Yang, Chenxiao Ye, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34528-e34528
Open Access | Times Cited: 2
Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response
Antonio Jesús Ruiz‐Malagón, Laura Hidalgo‐Garcia, María Jesús Rodríguez‐Sojo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114760-114760
Open Access | Times Cited: 6
Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients
Amr Elkholy, Nagavardhini Avuthu, Mohammed Abdalla, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18035-e18035
Open Access | Times Cited: 5
Chemopreventive effect of a milk whey by-product derived from Buffalo (Bubalus bubalis) in protecting from colorectal carcinogenesis
Nunzio Antonio Cacciola, Tommaso Venneri, Angela Salzano, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy
Norma Torres‐Carrillo, Erika Martínez‐López, Nora Magdalena Torres-Carrillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17100-17100
Open Access | Times Cited: 5
The Multifaceted Role and Regulation of Nlrp3 Inflammasome in Colitis-Associated Colo-Rectal Cancer: A Systematic Review
Roxana Zaharie, Dan Vălean, Călin Popa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3472-3472
Open Access | Times Cited: 4
The biofunction of Akkermansia muciniphila in intestinal-related diseases
Ping Jiang, Siqi Ji, Dan Su, et al.
Microbiome Research Reports (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Crosstalk between gut microbiota and cancer chemotherapy: current status and trends
Shanshan Yang, Shaodong Hao, Hui Ye, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Pharmacomicrobiomics-Guided Precision Oncology: A New Frontier of P4 (Predictive, Personalized, Preventive, and Participatory) Medicine and Microbiome-Based Therapeutics
Kazım Yalçın Arğa, Heba Attia, Ramy K. Aziz
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 1, pp. 5-7
Closed Access | Times Cited: 1
The role of human microbiota in the development of colorectal cancer: A literature review
Ariana Torres-Galarza, Zorayda Toledo, Natalia Bailón-Moscoso
Medicine in Microecology (2024) Vol. 20, pp. 100100-100100
Open Access | Times Cited: 1
Commentary: Intermittent Fasting and Akkermansia Muciniphila Potentiate the Antitumor Efficacy of FOLFOX in Colon Cancer
Junhong Su, Henri Braat, Auke P. Verhaar, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Colorectal Cancer and Microbiota Modulation for Clinical Use. A Systematic Review
Julio Madrigal‐Matute, Sara Bañón
Nutrition and Cancer (2022) Vol. 75, Iss. 1, pp. 123-139
Open Access | Times Cited: 3
Gut dysbiosis was inevitable, but tolerance was not: temporal responses of the murine microbiota that maintain its capacity for butyrate production correlate with sustained antinociception to chronic voluntary morphine
Izabella Sall, Randi Foxall, Lindsey Felth, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Crosstalk between gut microbiota and cancer chemotherapy: Current status and trends
Shanshan Yang, Shaodong Hao, Hui Ye, et al.
Research Square (Research Square) (2024)
Open Access
Advancing surgical prehabilitation through microbiota modulation
Wojciech Marlicz, Grażyna Rydzewska
Gastroenterology Review (2024) Vol. 19, Iss. 4, pp. 345-346
Open Access
A Mouse Model of Damp-Heat Syndrome with Pancreatic Cancer in Traditional Chinese Medicine and Its Characteristics of Gut Microbiome
Yangbo Tong, Han Fang, Mengyao Liu, et al.
Research Square (Research Square) (2024)
Open Access
Pasteurized Akkermansia muciniphila mitigates 5-FU-induced intestinal mucositis in tumor-bearing mice through suppression of the cGAS-STING pathway and epithelial cell apoptosis
Yue Teng, Jiahui Li, Chunhong Yan, et al.
Food Bioscience (2024) Vol. 61, pp. 104605-104605
Closed Access
Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model
Noriaki Oguri, Jun Miyoshi, Yuu Nishinarita, et al.
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access
Previous Page - Page 2

Scroll to top